Eurizon Capital SGR S.p.A. purchased a new stake in The Allstate Corporation (NYSE:ALL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 58,957 shares of the insurance provider's stock, valued at approximately $12,273,000.
Other hedge funds also recently made changes to their positions in the company. Dorato Capital Management acquired a new stake in shares of Allstate in the fourth quarter valued at approximately $27,000. Navalign LLC acquired a new stake in shares of Allstate in the fourth quarter valued at approximately $27,000. Princeton Global Asset Management LLC lifted its position in shares of Allstate by 101.3% in the fourth quarter. Princeton Global Asset Management LLC now owns 151 shares of the insurance provider's stock valued at $31,000 after buying an additional 76 shares during the last quarter. Palisade Asset Management LLC acquired a new stake in shares of Allstate in the third quarter valued at approximately $31,000. Finally, South Plains Financial Inc. lifted its position in shares of Allstate by 41.5% in the third quarter. South Plains Financial Inc. now owns 167 shares of the insurance provider's stock valued at $36,000 after buying an additional 49 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Allstate
In other Allstate news, COO Mario Rizzo sold 18,578 shares of Allstate stock in a transaction on Friday, May 1st. The stock was sold at an average price of $218.80, for a total value of $4,064,866.40. Following the completion of the transaction, the chief operating officer directly owned 82,227 shares of the company's stock, valued at $17,991,267.60. The trade was a 18.43% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mark Q. Prindiville sold 1,550 shares of Allstate stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $216.27, for a total value of $335,218.50. Following the completion of the transaction, the insider directly owned 27,558 shares of the company's stock, valued at $5,959,968.66. This represents a 5.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.55% of the stock is owned by insiders.
Trending Headlines about Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Allstate remains fundamentally strong after its latest quarter, with earnings per share and revenue both beating expectations, which supports the bull case for the stock. Insider Selling: Allstate NYSE: ALL Insider Sells 1,550 Shares of Stock
- Positive Sentiment: Several analyst and research notes continue to frame Allstate as undervalued or fairly attractive, and the stock still carries a moderate buy consensus with a higher average price target. Allstate (ALL) Down 4.6% Since Last Earnings Report: Can It Rebound?
- Neutral Sentiment: Allstate announced estimated April catastrophe losses of $870 million pre-tax, which is a reminder that weather-related claims can create earnings volatility and may temper sentiment near term. Is Allstate (ALL) the Most Undervalued Stock to Invest In?
- Neutral Sentiment: A consumer-focused article highlighting car insurance for road trips is not a direct company-specific catalyst, but it keeps attention on auto insurance demand and the broader insurance category. Driving instead of flying? Here's the best car insurance for road trips
- Negative Sentiment: One insider sold 1,550 shares, and while the sale was small relative to the company, insider selling can weigh on short-term sentiment. Insider Selling: Allstate NYSE: ALL Insider Sells 1,550 Shares of Stock
Allstate Stock Performance
NYSE:ALL opened at $206.51 on Monday. The stock has a market cap of $53.16 billion, a P/E ratio of 4.56, a PEG ratio of 0.37 and a beta of 0.19. The stock has a 50 day simple moving average of $212.70 and a 200 day simple moving average of $208.59. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.25. The Allstate Corporation has a 1-year low of $188.08 and a 1-year high of $227.62.
Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.65 earnings per share for the quarter, topping the consensus estimate of $7.31 by $3.34. The business had revenue of $16.94 billion during the quarter, compared to analysts' expectations of $15.24 billion. Allstate had a return on equity of 42.66% and a net margin of 17.81%.The firm's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the firm posted $3.53 EPS. Research analysts anticipate that The Allstate Corporation will post 29.11 earnings per share for the current year.
Allstate Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be issued a $1.08 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $4.32 annualized dividend and a yield of 2.1%. Allstate's payout ratio is currently 9.53%.
Analysts Set New Price Targets
A number of research firms have recently issued reports on ALL. Raymond James Financial reaffirmed a "strong-buy" rating and issued a $260.00 price objective on shares of Allstate in a research report on Tuesday, March 3rd. Wells Fargo & Company raised their price objective on Allstate from $229.00 to $243.00 and gave the company an "equal weight" rating in a research report on Wednesday, May 6th. Barclays raised their price objective on Allstate from $207.00 to $208.00 and gave the company an "underweight" rating in a research report on Wednesday, April 8th. Piper Sandler reaffirmed an "overweight" rating on shares of Allstate in a research report on Thursday. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $220.00 price objective on shares of Allstate in a research report on Thursday, February 5th. Three research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $241.67.
Read Our Latest Stock Analysis on Allstate
Allstate Profile
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.